Timothy MBA - AVTE Old CEO Director
| AVTEDelisted Stock | USD 93.80 0.70 0.75% |
Insider
Timothy MBA is CEO Director of AVTE Old
| Age | 63 |
| Phone | 617 443 2400 |
| Web | https://www.aerovatetx.com |
AVTE Old Management Efficiency
The company has return on total asset (ROA) of (0.3618) % which means that it has lost $0.3618 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5901) %, meaning that it created substantial loss on money invested by shareholders. AVTE Old's management efficiency ratios could be used to measure how well AVTE Old manages its routine affairs as well as how well it operates its assets and liabilities.AVTE Old currently holds 417 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. AVTE Old has a current ratio of 40.03, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about AVTE Old's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Piyush Patel | Tyra Biosciences | 60 | |
| Amy Conrad | Tyra Biosciences | N/A | |
| Lynn Scherm | Tyra Biosciences | N/A | |
| Jc MD | Adagene | 60 | |
| Guizhong Liu | Adagene | 54 | |
| Sean Jeffries | Design Therapeutics | 45 | |
| Paul Goodson | Cytek Biosciences | N/A | |
| Ming Yan | Cytek Biosciences | 62 | |
| Erick MD | Acrivon Therapeutics, Common | 67 | |
| Julie CPA | Design Therapeutics | N/A | |
| Fangyong Du | Adagene | 54 | |
| Robert Hudkins | Tyra Biosciences | 70 | |
| Connie Wedel | Cytek Biosciences | N/A | |
| Todd Garland | Cytek Biosciences | N/A | |
| Kristina Masson | Acrivon Therapeutics, Common | 44 | |
| Aseem Ansari | Design Therapeutics | N/A | |
| Chris Williams | Cytek Biosciences | 55 | |
| Daniel Bensen | Tyra Biosciences | 50 | |
| Daniel Faga | AnaptysBio | 45 | |
| Jesper Olsen | Acrivon Therapeutics, Common | N/A | |
| Joo MD | Design Therapeutics | 61 | |
Management Performance
| Return On Equity | -0.59 | |||
| Return On Asset | -0.36 |
AVTE Old Leadership Team
Elected by the shareholders, the AVTE Old's board of directors comprises two types of representatives: AVTE Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AVTE. The board's role is to monitor AVTE Old's management team and ensure that shareholders' interests are well served. AVTE Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AVTE Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Timothy Pigot, VP Commercial | ||
| Sanjeev Khindri, Executive Development | ||
| Benjamin Dake, President, Founder | ||
| Timothy MBA, CEO Director | ||
| Marinus Verwijs, Chief Officer | ||
| Stephen Yu, Senior Quality | ||
| BSc MD, Senior Development | ||
| Hunter MD, Chief Officer | ||
| MBA MR, Chief Officer | ||
| Susan Fischer, Executive Operations | ||
| Donna Dea, Head Affairs | ||
| George Eldridge, CFO Treasurer |
AVTE Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AVTE Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.59 | |||
| Return On Asset | -0.36 | |||
| Current Valuation | (526.15 K) | |||
| Shares Outstanding | 28.98 M | |||
| Shares Owned By Insiders | 0.01 % | |||
| Shares Owned By Institutions | 99.99 % | |||
| Number Of Shares Shorted | 4.59 M | |||
| Price To Earning | 0.64 X | |||
| Price To Book | 1.02 X | |||
| EBITDA | (74.31 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in AVTE Stock
If you are still planning to invest in AVTE Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AVTE Old's history and understand the potential risks before investing.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |